Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Jun 7;47(6):620-630.
doi: 10.1093/jpepsy/jsac001.

Racial Disparities in Medication Adherence Barriers: Pediatric Epilepsy as an Exemplar

Ana M Gutierrez-Colina  1 , Sara E Wetter  2 , Constance A Mara  1 , Shanna Guilfoyle  3 , Avani C Modi  4
Affiliations
Observational Study

Racial Disparities in Medication Adherence Barriers: Pediatric Epilepsy as an Exemplar

Ana M Gutierrez-Colina et al. J Pediatr Psychol. .

Abstract

Objective: To evaluate how racial disparities in medication adherence barriers relate to key clinical outcomes (i.e., seizure control and adherence) in pediatric epilepsy and to identify the most critical barriers in determining health outcomes in Black youth and White youth.

Methods: This observational study included a sample of youth aged 2-17 years with epilepsy obtained by combining data from four different studies. A total of 226 caregivers and 43 adolescents reported on adherence barriers. An electronic monitor was used to measure adherence to the primary antiepileptic drug. Racial disparities in individual barriers were examined. The relative importance of different types of barriers in determining clinical outcomes was evaluated in both Black and White youth.

Results: Adherence barriers, including running out of medications, access to pharmacies, competing demands, and difficulty swallowing, disproportionally affected Black children with epilepsy compared to White children. System- and community-level barriers emerged as the most important in determining seizure outcomes among Black youth. Both system- and individual-level barriers, on the other hand, were important for adherence outcomes.

Conclusions: System- and community-level barriers, as opposed to individual-level barriers, are more highly endorsed by Black families compared to White families. These barriers are also the most critical in driving seizure outcomes among Black youth. There is a critical need to shift from a primary focus on individual-level barriers to an approach that deliberately targets larger systemic barriers to reduce the existing adherence and health disparities that affect Black children with pediatric conditions.

Keywords: Black youth; children; compliance; seizures; self-management.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Level of barrier endorsement by parents of Black and White youth.
Figure 2.
Figure 2.
Level of barrier endorsement by Black and White youth.
Figure 3.
Figure 3.
Adherence barriers rankings by race and outcome.
See this image and copyright information in PMC

References

    1. Bautista R. E., Graham C., Mukardamwala S. (2011). Health disparities in medication adherence between African-Americans and Caucasians with epilepsy. Epilepsy & Behavior, 22(3), 495–498. 10.1016/j.yebeh.2011.07.032 - DOI - PubMed
    1. Berg J. S., Dischler J., Wagner D. J., Raia J. J., Palmer-Shevlin N. (1993). Medication compliance: A healthcare problem. Annals of Pharmacotherapy, 27(9 Suppl), S1–S24. - PubMed
    1. Bielby W. T., Hauser R. M., Featherman D. L. (1977). Response errors of black and nonblack males in models of the intergenerational transmission of socioeconomic status. American Journal of Sociology, 82(6), 1242–1288.
    1. Crocker D., Brown C., Moolenaar R., Moorman J., Bailey C., Mannino D., Holguin F. (2009). Racial and ethnic disparities in asthma medication usage and health-care utilization: Data from the National Asthma Survey. Chest, 136(4), 1063–1071. 10.1378/chest.09-0013 - DOI - PubMed
    1. Cutler R. L., Fernandez-Llimos F., Frommer M., Benrimoj C., Garcia-Cardenas V. (2018). Economic impact of medication non-adherence by disease groups: A systematic review. BMJ Open, 8(1), e016982.10.1136/bmjopen-2017-016982 - DOI

Publication types

Substances